Panacea Biotec is trading higher by 7% at Rs 122 after the biotechnology company said that it has received an order worth of Rs 187 crore from the Government of India for supply of oral polio vaccine.
“The company gets Government of India’s orders for supply of 345 million doses of Trivalent Oral Polio Vaccines (tOPV) and Bivalent Oral Polio Vaccine (bOPV) worth Rs 188 crore, to be supplied during the period December 2012 till May 2013 to meet the requirements of National Immunisation Days (NIDs) and Supplementary National Immunisation Days (SNIDs),” Panacea Biotec said in a filing.
The stock opened at Rs 117 and hit a high of Rs 126 on the NSE. A combined 112,579 shares have changed hands on the counter so far on both the exchanges.